Literature DB >> 20155840

Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.

Christoph Walz1, David Grimwade, Susanne Saussele, Eva Lengfelder, Claudia Haferlach, Susanne Schnittger, Marina Lafage-Pochitaloff, Andreas Hochhaus, Nicholas C P Cross, Andreas Reiter.   

Abstract

Reciprocal RARA-PML transcripts are not detected in approximately 25% of patients with PML-RARA positive acute promyelocytic leukemia (APL), but the reasons for this are poorly understood. We studied 21 PML-RARA positive/RARA-PML negative cases by bubble PCR and multiplex long template PCR to identify the genomic breakpoints. Additional RT-PCR analysis was performed based on the DNA findings. Three cases were found to have complex rearrangements involving a third locus: the first had a PML-CDC6-RARA forward DNA fusion and expressed a chimeric PML-CDC6-RARA mRNA in addition to a PML-RARA. The other two had HERC1-PML and NT_009714.17-PML genomic fusion sequences at their respective reciprocal breakpoints. Six patients were falsely classified as RARA-PML negative due to deletions on chromosome 15 and/or 17, or alternative splicing leading to atypical RARA-PML fusion transcripts, which were not identified by conventional RT-PCR assays. This study demonstrates that the frequency of RARA-PML expression has been underestimated and highlights remarkable complexity at chromosomal breakpoint regions in APL even in cases with an apparently simple balanced t(15;17)(q24;q12). (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155840     DOI: 10.1002/gcc.20757

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  CDC6 expression is regulated by lineage-specific transcription factor GATA1.

Authors:  Bárbara Fernández-Morales; Leticia Pavón; Carmela Calés
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

2.  Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

Authors:  John S Welch; Peter Westervelt; Li Ding; David E Larson; Jeffery M Klco; Shashikant Kulkarni; John Wallis; Ken Chen; Jacqueline E Payton; Robert S Fulton; Joelle Veizer; Heather Schmidt; Tammi L Vickery; Sharon Heath; Mark A Watson; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson
Journal:  JAMA       Date:  2011-04-20       Impact factor: 56.272

3.  A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).

Authors:  Kentaro Hirade; Shigeru Kusumoto; Akihiro Abe; Hatsune Noritake; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Shinsuke Iida; Yukiya Yamamoto
Journal:  Int J Hematol       Date:  2022-07-19       Impact factor: 2.319

4.  High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.

Authors:  Zeba N Singh; Vu H Duong; Rima Koka; Ying Zou; Sameer Sawhney; Li Tang; Maria R Baer; Nicholas Ambulos; Firas El Chaer; Ashkan Emadi
Journal:  J Hematop       Date:  2018-08-09       Impact factor: 0.196

5.  Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.

Authors:  Zhanglin Zhang; Yawen Xu; Mei Jiang; Fancong Kong; Zhiwei Chen; Shuyuan Liu; Fei Li
Journal:  Cancer Biol Ther       Date:  2020-01-20       Impact factor: 4.742

Review 6.  Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.

Authors:  Gerald B W Wertheim; Elizabeth Hexner; Adam Bagg
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

7.  New chimeric RNAs in acute myeloid leukemia.

Authors:  Florence Rufflé; Jerome Audoux; Anthony Boureux; Sacha Beaumeunier; Jean-Baptiste Gaillard; Elias Bou Samra; Andre Megarbane; Bruno Cassinat; Christine Chomienne; Ronnie Alves; Sebastien Riquier; Nicolas Gilbert; Jean-Marc Lemaitre; Delphine Bacq-Daian; Anne Laure Bougé; Nicolas Philippe; Therese Commes
Journal:  F1000Res       Date:  2017-08-02

8.  [Cytogenetic test and clinical study on cryptic acute promyelocytic leukemia with ins (15; 17)].

Authors:  J Zhou; J W Zhao; Y C Zheng; J Xiao; C W Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-10-14

9.  Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.

Authors:  E H A Dekking; V H J van der Velden; R Varro; H Wai; S Böttcher; M Kneba; E Sonneveld; A Koning; N Boeckx; N Van Poecke; P Lucio; A Mendonça; L Sedek; T Szczepański; T Kalina; V Kanderová; P Hoogeveen; J Flores-Montero; M C Chillón; A Orfao; J Almeida; P Evans; M Cullen; A L Noordijk; P M Vermeulen; M T de Man; E P Dixon; W M Comans-Bitter; J J M van Dongen
Journal:  Leukemia       Date:  2012-05-08       Impact factor: 11.528

10.  Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS.

Authors:  Anna Stengel; Rabia Shahswar; Torsten Haferlach; Wencke Walter; Stephan Hutter; Manja Meggendorfer; Wolfgang Kern; Claudia Haferlach
Journal:  Blood Adv       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.